Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib plus docetaxel versus docetaxel in advanced non-small cell lung cancer
2011-001084-42Phase 2Completed
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in non-small cell lung cancer (NSCLC), sponsored by Synta Pharmaceuticals Corp.. Started May 2011; status: completed.
02
Drugs
ganetespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2011-001084-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001084-42.